Logo

A Friendly Ghostwritten Paper for Paxil

Aug 21, 2009

Merck and Wyeth weren't the only ones. The Associated Press reports that GlaxoSmithKline had a ghostwriting program to support its antidepressant, Paxil. The program, called CASSPER, instructed salespeople to approach physicians and help them write and publish positive articles about the antidepressant. Los Angeles law firm Baum Hedlund is suing GSK and says they downplayed the risks of the drug. GSK says the program was discontinued many years ago.

Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.